综上所述，免疫治疗联合化疗对晚期胃癌患者疗效显著，不良反应无明显增加，

In summary, immunotherapy combined with chemotherapy has a significant effect on patients with advanced gastric cancer, with no significant increase in adverse reactions, significant improvement in physical and nutritional status, and significant improvement in T lymphocyte function. The clinical value is significantly higher than that of chemotherapy alone. <br><br>Nevertheless, the shortcomings can still be seen in this study: small sample size, short follow-up time, in addition, in consideration of the stability of the research indicators, T lymphocyte subsets were included in the study but not the patient’s blood immune cells The protein content was analyzed and studied to further confirm the effect of the treatment program on the patient's humoral immunity. <br><br><br>Active countermeasures are being taken to accumulate cases and relevant experience, and to further increase the research content of humoral immunity, in order to more comprehensively evaluate the benefits of the treatment plan for patients. <br>references

In summary, immunotherapy combined chemotherapy was effective in patients with advanced stomach cancer, adverse reactions were not significantly increased, physical condition and nutritional status improved significantly, and T lymphocyte function was significantly improved. The clinical value is significantly higher than that of chemotherapy alone.<br><br>Nevertheless, the shortcomings can still be seen in this study: less sample content, short follow-up time, in addition, for the stability of the study indicators, T lymphocyte sub-groups were included in the study without the patient's blood immunoglobulin content analysis study, to further confirm the effect of the treatment program on the patient's body fluid immunity.<br><br>Positive responses are being taken to build on cases and related experiences and to further increase the content of research on body fluid immunity with a view to a more comprehensive assessment of the benefits of the treatment to patients.<br>References

In conclusion, immunotherapy combined with chemotherapy has a significant effect on patients with advanced gastric cancer, with no significant increase in adverse reactions, significant improvement in physical and nutritional status, and significant improvement in T lymphocyte function. The clinical value was significantly higher than that of chemotherapy alone.<br>However, the shortcomings can still be seen in this study: small sample size, short follow-up time, in addition, for the stability of research indicators, T lymphocyte subsets were included in the study, but the blood immunoglobulin content of patients was not analyzed, so as to further confirm the impact of the treatment scheme on humoral immunity of patients.<br>Positive response measures are being taken to accumulate cases and relevant experience, and further increase the research content of humoral immunity, so as to more comprehensively evaluate the benefits of the treatment for patients.<br>reference